Reinduction of relapsed acute promyelocytic leukemia with ATRA and low dose antimetabolite-based chemotherapy

Pediatric Blood and Cancer

Volumn 48, Issue 5, 2007, Pages 582-585

  Dvorak, Christopher C ^a   Sanders, Robert P ^b   Dahl, Gary V H ^a   Donaldson, Sarah S ^a   Razzouk, Bassem I ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

6 mercaptopurine; ATRA; Induction; Methotrexate; Relapsed APML

Indexed keywords

ANTIMETABOLITE; ARSENIC TRIOXIDE; BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; FLUDARABINE; GEMTUZUMAB OZOGAMICIN; HYDROCORTISONE; MELPHALAN; RETINOIC ACID; RITUXIMAB; THIOTEPA;

ARTICLE; BONE MARROW; BRAIN HEMORRHAGE; CANCER PATIENT; CASE REPORT; DISEASE FREE SURVIVAL; DRUG SAFETY; FEMALE; GRAND MAL SEIZURE; HEMATOPOIETIC STEM CELL; HEMORRHAGIC CYSTITIS; HUMAN; LEUKEMIA RELAPSE; LEUKOCYTOSIS; LOW DRUG DOSE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; TONIC CLONIC SEIZURE; TREATMENT OUTCOME; VIRUS INFECTION;

6-MERCAPTOPURINE; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LEUKEMIA, PROMYELOCYTIC, ACUTE; METHOTREXATE; RECURRENCE; REMISSION INDUCTION; TRETINOIN;

EID: 33947691783     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20592     Document Type: Article

References (20)

1. Mann G, Reinhardt D, Ritter J, et al. Treatment with all-trans retinoic acid in acute promyelocytic leukemia reduces early deaths in children. Ann Hematol 2001;80:417-422.
2. de Botton S, Coiteux V, Chevret S, et al. Outcome of childhood acute promyelocytic leukemia with all-trans retinoic acid and chemotherapy. J Clin Oncol 2004;22:1404-1412.
3. Ohno R, Asou N, Ohnishi K. Treatment of acute promyelocytic leukemia: Strategy toward further increase of cure rate. Leukemia 2003;17:1454-1463.
4. Fox E, Adamson PC, Murgo A, et al. Phase i trial and pharmacokinetic study of arsenic trioxide in children with refractory leukemia. ASCO Proc 2002;21:396a.
5. Estey EH. Treatment options for relapsed acute promyelocytic leukemia. Best Pract Res Clin Haematol 2003;16:521-534.
6. Nabhan C, Mehta J, Tallman MS. The role of bone marrow transplantation in acute promyelocytic leukemia. Bone Marrow Transplant 2001;28:219-226.
7. Wadleigh M, Richardson PG, Zahrieh D, et al. Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation. Blood 2003;102:1578-1582.
8. Raelson JV, Nervi C, Rosenauer A, et al. The pml/rar alpha oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells. Blood 1996;88:2826-2832.
9. Cai X, Shen YL, Zhu Q, et al. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia. Leukemia 2000; 14:262-270.
10. Bodner AJ, Ting RC, Gallo RC. Induction of differentiation of human promyelocytic leukemia cells (hl-60) by nucleosides and methotrexate. J Natl Cancer Inst 1981;67:1025-1030.
11. Sokoloski JA, Beardsley GP, Sartorelli AC. Mechanism of the induction of the differentiation of hl-60 leukemia cells by antifolates. Cancer Commun 1989;1:199-207.
12. Dalton WT, Ahearn MJ, McCredie KB, et al. Hl-60 cell line was derived from a patient with fab-m2 not not fab-m3. Blood 1988;71:242-247.
13. Fenaux P, Chastang C, Chevret S, et al. A randomized comparison of all trans retinoic acid (atra) followed by chemotherapy and atra plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. Blood 1999;94:1192-1200.
14. Grimwade D, Jamal R, Goulden N, et al. Salvage of patients with acute promyelocytic leukaemia with residual disease following abmt performed in second cr using all-trans retinoic acid. Br J Haematol 1998;103:559-562.
15. Ferrara F, Selleri C, Mele G, et al. Late relapse of acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy: Report of two cases. Ann Hematol 2004;83:484-486.
16. Visani G, Buonamici S, Malagola M, et al. Pulsed atra as single therapy restores long-term remission in pml-raralpha-positive acute promyelocytic leukemia patients: Real time quantification of minimal residual disease. A pilot study. Leukemia 2001; 15:1696-1700.
17. 2) in acute promyelocytic leukemia. Blood 1993;82:3560-3563.
18. Larson RS, Tallman MS. Retinoic acid syndrome: Manifestations, pathogenesis, and treatment. Best Pract Res Clin Haematol 2003; 16:453-461.
19. Al-Saad K, Khanani MF, Naqvi A, et al. Sweet syndrome developing during treatment with all-trans retinoic acid in a child with acute myelogenous leukemia. J Pediatr Hematol Oncol 2004;26:197-199.
20. Camacho LH, Soignet SL, Chanel S, et al. Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide. J Clin Oncol 2000;18: 2620-2625.